NIH and FDA Announce Collaborative Initiative to Fast-track …
The U.S. Food and Drug Administration and the National Institutes of Health today unveiled an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients.
FDA-NIH Biomarker Working Group
Jan 28, 2016 · NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]. Silver Spring (MD): Food and Drug Administration (US); 2016-. Co-published by National Institutes of Health (US), Bethesda (MD).
NIH and FDA leaders call for innovation in development of …
Oct 15, 2024 · In a new commentary in the Annals of Internal Medicine, leaders at the National Institutes of Health (NIH) and U.S. Food and Drug Administration (FDA) highlight recommendations and opportunities to promote innovation in research and development of smoking cessation therapies, for which there is an urgent …
List of Institutes and Centers - National Institutes of Health (NIH)
Nov 18, 2024 · The mission of the National Institute on Drug Abuse (NIDA) is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health.
Office of Dietary Supplements (ODS)
Health Information. Provides the latest scientific information on dietary supplements in fact sheets, videos, and other federal resources.
NIDA.NIH.GOV | National Institute on Drug Abuse (NIDA)
NIDA's mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. NIDA is one of the National Institutes of Health.
Accelerating Medicines Partnership - National Institutes of Health …
Launched in 2014, the Accelerating Medicines Partnership ® (AMP ®) program is a public-private partnership between the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical and life science companies, non-profit and other organizations to transform the current model for developing new ...
NIH, FDA and 15 private organizations join forces to increase …
The National Institutes of Health, U.S. Food and Drug Administration, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for the 30 million Americans who suffer from a rare disease.
BEST (Biomarkers, EndpointS, and other Tools) Resource
Jan 28, 2016 · The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) are joint sponsors of the BEST (Biomarkers, EndpointS, and other Tools) Resource.
National Institute on Drug Abuse (NIDA) | National Institutes of …
Mar 6, 2024 · The National Institute on Drug Abuse (NIDA) is the lead federal agency supporting scientific research on drug use and addiction. NIDA’s mission is to advance science on drug use and addiction and to apply that knowledge to improve individual and public health.